Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 23180.00% is 348% above its 1-year average of 5170.00%, near the high end of its 1-year range (-12840.00%–23180.00%).
As of the fiscal period ended Monday, December 31, 2018.
Reported quarterly EBITDA margin; no daily interpolation.
Limited quarterly history available
EBITDA Margin needs at least three reported quarters before a meaningful chart is shown.
EBITDA MARGIN
23180.00%
EBITDA MARGIN AVG TTM
N/A
EBITDA MARGIN AVG 3Y
N/A
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$3.50M
EBITDA Margin
3.53%
TTM Avg
-69.60%
3Y Avg
-286.97%
5Y Avg
-286.97%
Market Cap
$3.53M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.63M
EBITDA Margin
-16.02%
TTM Avg
-16.02%
3Y Avg
-6.88%
5Y Avg
6.20%
Market Cap
$3.65M
EBITDA Margin
-2411.68%
TTM Avg
-15920.55%
3Y Avg
-15920.55%
5Y Avg
-10610.40%
Market Cap
$3.65M
EBITDA Margin
-334.54%
TTM Avg
-323.48%
3Y Avg
-700.81%
5Y Avg
-1335.84%
Market Cap
$3.30M
EBITDA Margin
-2774.55%
TTM Avg
-3680.87%
3Y Avg
-3159.91%
5Y Avg
-3026.36%
Market Cap
$3.28M
EBITDA Margin
-7.62%
TTM Avg
-1345.01%
3Y Avg
-903.09%
5Y Avg
-551.32%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mustang Bio, Inc. (MBIO) | $3.49M | 23180.00% | N/A | N/A | N/A |
| Eocene Ltd. (EOCN)vs › | $3.50M | N/A | N/A | N/A | N/A |
| Moolec Science S.A. (MLEC)vs › | $3.50M | 3.53% | -69.60% | -286.97% | -286.97% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.53M | N/A | N/A | N/A | N/A |
| WORK Medical Technology Group Ltd. Class A (WOK)vs › | $3.63M | -16.02% | -16.02% | -6.88% | 6.20% |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.65M | -2411.68% | -15920.55% | -15920.55% | -10610.40% |
| Evogene Ltd. (EVGN)vs › | $3.65M | -334.54% | -323.48% | -700.81% | -1335.84% |
| Nexalin Technology, Inc. (NXL)vs › | $3.30M | -2774.55% | -3680.87% | -3159.91% | -3026.36% |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.28M | -7.62% | -1345.01% | -903.09% | -551.32% |
| MBody AI Ltd. (MBAI)vs › | $3.25M | N/A | N/A | N/A | N/A |
Gross Margin
0.0%
EBITDA Margin
23180.0%
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2018-12-31 | 23180.00% |
| 2018-03-31 | -12840.00% |
